目次

Table of Contents

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Type
Market segments
Comparison by Type
Biologics - Market size and forecast 2020-2025
Small molecules - Market size and forecast 2020-2025
Market opportunity by Type

Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Vendor Landscape
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
AFM-Telethon
Capricor Therapeutics Inc.
CRISPR Therapeutics AG
Daiichi Sankyo Co. Ltd.
Editas Medicine Inc.
F. Hoffmann-La Roche Ltd.
Italfarmaco Spa
Nippon Shinyaku Co. Ltd.
Pfizer Inc.
PTC Therapeutics Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Type - Market share 2020-2025 (%)
22: Comparison by Type
23: Biologics - Market size and forecast 2020-2025 ($ million)
24: Biologics - Year-over-year growth 2020-2025 (%)
25: Small molecules - Market size and forecast 2020-2025 ($ million)
26: Small molecules - Year-over-year growth 2020-2025 (%)
27: Market opportunity by Type
28: Customer landscape
29: Market share By Geographical Landscape 2020-2025 (%)
30: Geographic comparison
31: North America - Market size and forecast 2020-2025 ($ million)
32: North America - Year-over-year growth 2020-2025 (%)
33: Europe - Market size and forecast 2020-2025 ($ million)
34: Europe - Year-over-year growth 2020-2025 (%)
35: Asia - Market size and forecast 2020-2025 ($ million)
36: Asia - Year-over-year growth 2020-2025 (%)
37: ROW - Market size and forecast 2020-2025 ($ million)
38: ROW - Year-over-year growth 2020-2025 (%)
39: Key leading countries
40: Market opportunity By Geographical Landscape ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: AFM-Telethon - Overview
48: AFM-Telethon - Product and service
49: AFM-Telethon - Key offerings
50: AFM-Telethon - Key customers
51: AFM-Telethon - Segment focus
52: Capricor Therapeutics Inc. - Overview
53: Capricor Therapeutics Inc. - Business segments
54: Capricor Therapeutics Inc. - Key offerings
55: Capricor Therapeutics Inc. - Key customers
56: Capricor Therapeutics Inc. - Segment focus
57: CRISPR Therapeutics AG - Overview
58: CRISPR Therapeutics AG - Business segments
59: CRISPR Therapeutics AG - Key offerings
60: CRISPR Therapeutics AG - Key customers
61: CRISPR Therapeutics AG - Segment focus
62: Daiichi Sankyo Co. Ltd. - Overview
63: Daiichi Sankyo Co. Ltd. - Business segments
64: Daiichi Sankyo Co. Ltd. - Key offerings
65: Daiichi Sankyo Co. Ltd. - Key customers
66: Daiichi Sankyo Co. Ltd. - Segment focus
67: Editas Medicine Inc. - Overview
68: Editas Medicine Inc. - Business segments
69: Editas Medicine Inc. - Key offerings
70: Editas Medicine Inc. - Key customers
71: Editas Medicine Inc. - Segment focus
72: F. Hoffmann-La Roche Ltd. - Overview
73: F. Hoffmann-La Roche Ltd. - Business segments
74: F. Hoffmann-La Roche Ltd. - Key offerings
75: F. Hoffmann-La Roche Ltd. - Key customers
76: F. Hoffmann-La Roche Ltd. - Segment focus
77: Italfarmaco Spa - Overview
78: Italfarmaco Spa - Product and service
79: Italfarmaco Spa - Key offerings
80: Italfarmaco Spa - Key customers
81: Italfarmaco Spa - Segment focus
82: Nippon Shinyaku Co. Ltd. - Overview
83: Nippon Shinyaku Co. Ltd. - Business segments
84: Nippon Shinyaku Co. Ltd. - Key offerings
85: Nippon Shinyaku Co. Ltd. - Key customers
86: Nippon Shinyaku Co. Ltd. - Segment focus
87: Pfizer Inc. - Overview
88: Pfizer Inc. - Business segments
89: Pfizer Inc. - Key offerings
90: Pfizer Inc. - Key customers
91: Pfizer Inc. - Segment focus
92: PTC Therapeutics Inc. - Overview
93: PTC Therapeutics Inc. - Business segments
94: PTC Therapeutics Inc. - Key offerings
95: PTC Therapeutics Inc. - Key customers
96: PTC Therapeutics Inc. - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations